Venture Map · Round

AntalGenics — Seed · €808K

Announced 2022-02-17 · Elche · Biotech

AntalGenics, a sensory neurobiology spin-off based at Miguel Hernández University's science park in Elche, raised €807,723 through the life-sciences equity crowdfunding platform Capital Cell to develop a neuro-drug that eliminates chronic itching in psoriasis. Inveready and private investors Antonio Ferrer and Antonio Parente also took part; no lead was stated.

RoundSeed Amount€808K LeadNot disclosed Date2022-02-17 CityElche SectorBiotech

Source article ↗ · antalgenics.com ↗

The company

Investors 4

Antonio Ferrer
InvestorSpain
Antonio Parente
InvestorSpain
Capital Cell
capitalcell.com
InvestorSpain
Inveready
www.inveready.com
InvestorSpain

← All funding rounds

Start typing to search across everything.
↑↓ navigate↵ openesc close